Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Profit Before Tax

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Profit Before Tax History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax ₹1,399 Cr₹36 Cr₹240 Cr₹1,441 Cr₹1,382 Cr

What is the latest Profit Before Tax of GLENMARK PHARMACEUTICALS ?

The latest Profit Before Tax ratio of GLENMARK PHARMACEUTICALS is ₹1,399 Cr based on Mar2026 Consolidated results.
Year Profit Before Tax
Mar2026₹1,399 Cr
Mar2025₹36 Cr
Mar2024₹240 Cr
Mar2023₹1,441 Cr
Mar2022₹1,382 Cr

How is Profit Before Tax of GLENMARK PHARMACEUTICALS Trending?

Years Profit Before Tax % Change
Mar2026 ₹1,399 Cr
3,733.97
Mar2025 ₹36 Cr
-84.78
Mar2024 ₹240 Cr
-83.36
Mar2023 ₹1,441 Cr
4.25
Mar2022 ₹1,382 Cr -

Compare Profit Before Tax of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,359.1 Cr -5.4% -10.3% 16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-5.4%

-10.3%

16.8%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses